Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AGIO

Agios Pharmaceuticals Inc

May 22 • 04:00PM ET

28.14

-0.65 -2.26 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NRIX KYMR RYTM BEAM XENE

| Held by: XBI VTI VB IWM VBK VXF IWN IBB SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-7.25	Insider Own	6.35%	Shs Outstand	59.34M	Perf Week	-0.11%
Market Cap	1.67B	Forward P/E	-	EPS next Y	-4.68	Insider Trans	-2.87%	Shs Float	55.70M	Perf Month	9.32%
Enterprise Value	972.23M	PEG	-	EPS next Q	-1.61	Inst Own	105.57%	Short Float	12.52%	Perf Quarter	-6.82%
Income	-422.60M	P/S	25.34	EPS this Y	13.91%	Inst Trans	-1.27%	Short Ratio	6.69	Perf Half Y	25.96%
Sales	66.05M	P/B	1.51	EPS next Y	23.68%	ROA	-30.84%	Short Interest	6.97M	Perf YTD	3.38%
Book/sh	18.69	P/C	2.27	EPS next 5Y	23.25%	ROE	-32.82%	52W High	46.00 -38.83%	Perf Year	-4.90%
Cash/sh	12.39	P/FCF	-	EPS past 3/5Y	-18.95% -8.46%	ROIC	-37.53%	52W Low	22.24 26.53%	Perf 3Y	5.43%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	55.97% -	Gross Margin	82.07%	Volatility	3.84% 4.05%	Perf 5Y	-50.73%
Dividend TTM	-	EV/Sales	14.72	EPS Y/Y TTM	-161.91%	Oper. Margin	-719.97%	ATR (14)	1.21	Perf 10Y	-38.07%
Dividend Ex-Date	-	Quick Ratio	13.59	Sales Y/Y TTM	78.34%	Profit Margin	-639.84%	RSI (14)	47.77	Recom	1.60
Dividend Gr. 3/5Y	- -	Current Ratio	14.19	EPS Q/Q	-8.50%	SMA20	1.60%	Beta	0.58	Target Price	41.12
Payout	-	Debt/Eq	0.03	Sales Q/Q	137.75%	SMA50	-4.50%	Rel Volume	0.84	Prev Close	28.79
Employees	540	LT Debt/Eq	0.02	Earnings	Apr 29 BMO	SMA200	-13.26%	Avg Volume	1.04M	Price	28.14
IPO	Jul 24, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.29% 55.98%	Trades		Volume	874,481	Change	-2.26%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)